Tabasi 2020.
Study name | Determining the effectiveness of transcranial direct current stimulation (tDCS) and omega‐3 supplementation on executive functions, food craving, and depressive symptoms in patients with depression and overweight |
Methods | Randomised placebo‐controlled trial |
Participants | Participants: Women with depression (Beck Depression Score above 14), overweight or obese (BMI ≥ 25) and age group 18 to 60 years |
Interventions | Intervention: Intervention group 1: 3 sessions of transcranial direct current stimulation (tDCS), plus omega‐3 supplement (5 cc daily, containing 736 mg (EPA) And 460 mg (DHA)) Intervention group 2: 3 sessions of transcranial direct current stimulation (tDCS), plus omega‐3 placebo supplement (5 cc daily, soybean oil) Intervention group 3: 3 sessions of sham transcranial direct current stimulation (tDCS), plus omega‐3 supplement (5 cc daily, containing 736 mg of eicosapentaenoic acid (EPA) and 460 mg docosahexaenoic acid (DHA)).0 mg DHA) Comparator: 3 sessions of sham transcranial direct current stimulation (tDCS), and the placebo of omega‐3 (5 cc daily, soybean oil) |
Outcomes | Primary: BDI, at baseline, 14 and 28 days Secondary: Executive function (Simple Strop computer software and Wisconsin card computer test), Individual cravings score in the Summary Food Trait Questionnaire (FCQ‐T), body weight and body fat percentage, appetite score (Simple Appetite Questionnaire (SNAQ) at baseline, 14 and 28 days |
Starting date | December 2019 |
Contact information | Seyed Ali Mostafavi, Tehran University of Medical Sciences, Iran |
Notes | Irct20200716048117N |